Patents by Inventor Brendan E. Koop

Brendan E. Koop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11020595
    Abstract: Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: June 1, 2021
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventor: Brendan E. Koop
  • Patent number: 10946202
    Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: March 16, 2021
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
  • Patent number: 10806931
    Abstract: Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may include a tubular member and a distal holding section extending distally of a distal end of the tubular member and defining a cavity therein for receiving an implantable leadless pacing device. The delivery device may facilitate vascular delivery of the pacing device to a left side of a patient's heart. In one example, a distal tip portion may extend distal of the distal holding section and may be actuated between a closed and an opened position. When in the closed position, the distal tip portion may have a tip that can puncture or engage an opening in a septum between a left atrium and a right atrium of a patient's heart. Actuating the distal tip portion to an opened position may be utilized to dilate the puncture or opening in the septum.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: October 20, 2020
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Allan C. Shuros, Arjun D. Sharma, James V. Kauphusman, Brendan E. Koop, Brian Soltis
  • Patent number: 10722684
    Abstract: Catheter and implantable leadless pacing devices, systems, and methods utilizing catheters and implantable leadless pacing devices are disclosed. An example catheter system may include a holding structure extending distally from a tubular member. An implantable device, such as a leadless pacing device, may be located within a cavity of the holding structure. The holding structure may include one or more electrical ports adjacent the proximal end of the holding structure and adjacent or proximal of the proximal end of the implantable device. The electrical ports may provide a conductive pathway extending through the distal structure to allow electrical signals to pass through the distal structure to and/or from the implantable device.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 28, 2020
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Brian Soltis, Brendan E. Koop, Benjamin J. Haasl, Kurt G. Koubal, James P. Goodman, Vincent P. Hackenmueller
  • Publication number: 20200094063
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Application
    Filed: November 12, 2019
    Publication date: March 26, 2020
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: STEPHEN J. HAHN, KRZYSZTOF Z. SIEJKO, WILLIAM J. LINDER, KEITH R. MAILE, AMY JEAN BRISBEN, KEITH L. HERRMANN, BRENDAN E. KOOP, BENJAMIN J. HAASL
  • Patent number: 10512784
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: December 24, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, William J. Linder, Keith R. Maile, Amy Jean Brisben, Keith L. Herrmann, Brendan E. Koop, Benjamin J. Haasl
  • Publication number: 20190351236
    Abstract: An implantable medical device (IMD) may include a housing having a proximal end and a distal end and a set of one or more electrodes connected to but spaced apart from the housing. The IMD may further include a controller disposed within the housing, wherein the controller is configured to sense cardiac electrical signals, and deliver electrical stimulation pulses via the first set of one or more electrodes. In some embodiments, a first portion of the housing is configured to be disposed at least partly within a coronary sinus of a patient's heart and a second portion of the housing is configured to be disposed at least partly within a right atrium of the patient's heart.
    Type: Application
    Filed: July 30, 2019
    Publication date: November 21, 2019
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventor: Brendan E. Koop
  • Publication number: 20190329060
    Abstract: A subcutaneous implantable cardioverter-defibrillator (S-ICD) comprising shocking electrodes configured to reduce the defibrillation threshold. The S-ICD may include a canister housing a source of electrical energy, a capacitor, and operational circuitry that senses heart rhythms and an electrode and lead assembly. The electrode and lead assembly may comprise a lead, at least one sensing electrode, and at least one shocking electrode. The at least one shocking electrode may extend over a length in the range of 50 to 110 millimeters and a width in the range of 1 to 40 millimeters.
    Type: Application
    Filed: July 11, 2019
    Publication date: October 31, 2019
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: ANDREW L. DE KOCK, G. SHANTANU REDDY, ROBERT D. BROCK, II, STEPHEN J. HAHN, BRENDAN E. KOOP, MOIRA B. SWEENEY, WYATT K. STAHL
  • Patent number: 10398901
    Abstract: An implantable medical device (IMD) may include a housing having a proximal end and a distal end and a set of one or more electrodes connected to but spaced apart from the housing. The IMD may further include a controller disposed within the housing, wherein the controller is configured to sense cardiac electrical signals, and deliver electrical stimulation pulses via the first set of one or more electrodes. In some embodiments, a first portion of the housing is configured to be disposed at least partly within a coronary sinus of a patient's heart and a second portion of the housing is configured to be disposed at least partly within a right atrium of the patient's heart.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: September 3, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventor: Brendan E. Koop
  • Patent number: 10391325
    Abstract: A subcutaneous implantable cardioverter-defibrillator (S-ICD) comprising shocking electrodes configured to reduce the defibrillation threshold. The S-ICD may include a canister housing a source of electrical energy, a capacitor, and operational circuitry that senses heart rhythms and an electrode and lead assembly. The electrode and lead assembly may comprise a lead, at least one sensing electrode, and at least one shocking electrode. The at least one shocking electrode may extend over a length in the range of 50 to 110 millimeters and a width in the range of 1 to 40 millimeters.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: August 27, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Andrew L. De Kock, G. Shantanu Reddy, Robert D. Brock, II, Stephen J. Hahn, Brendan E. Koop, Moira B. Sweeney, Wyatt K. Stahl
  • Publication number: 20190175927
    Abstract: Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.
    Type: Application
    Filed: February 19, 2019
    Publication date: June 13, 2019
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventor: Brendan E. Koop
  • Publication number: 20190143130
    Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 16, 2019
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
  • Patent number: 10238882
    Abstract: Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: March 26, 2019
    Assignee: CARDIAC PACEMAKERS
    Inventor: Brendan E. Koop
  • Patent number: 10213610
    Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: February 26, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
  • Publication number: 20180323865
    Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.
    Type: Application
    Filed: July 12, 2018
    Publication date: November 8, 2018
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Jacob M. Ludwig, Michael J. Kane, Brendan E. Koop, William J. Linder, Keith R. Maile, Jeffrey E. Stahmann
  • Patent number: 10050700
    Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: August 14, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jacob M. Ludwig, Michael J. Kane, Brendan E. Koop, William J. Linder, Keith R. Maile, Jeffrey E. Stahmann
  • Publication number: 20180178007
    Abstract: Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may include a tubular member and a distal holding section extending distally of a distal end of the tubular member and defining a cavity therein for receiving an implantable leadless pacing device. The delivery device may facilitate vascular delivery of the pacing device to a left side of a patient's heart. In one example, a distal tip portion may extend distal of the distal holding section and may be actuated between a closed and an opened position. When in the closed position, the distal tip portion may have a tip that can puncture or engage an opening in a septum between a left atrium and a right atrium of a patient's heart. Actuating the distal tip portion to an opened position may be utilized to dilate the puncture or opening in the septum.
    Type: Application
    Filed: December 22, 2017
    Publication date: June 28, 2018
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: ALLAN C. SHUROS, ARJUN D. SHARMA, JAMES V. KAUPHUSMAN, BRENDAN E. KOOP, BRIAN SOLTIS
  • Publication number: 20180177979
    Abstract: Catheter and implantable leadless pacing devices, systems, and methods utilizing catheters and implantable leadless pacing devices are disclosed. An example catheter system may include a holding structure extending distally from a tubular member. An implantable device, such as a leadless pacing device, may be located within a cavity of the holding structure. The holding structure may include one or more electrical ports adjacent the proximal end of the holding structure and adjacent or proximal of the proximal end of the implantable device. The electrical ports may provide a conductive pathway extending through the distal structure to allow electrical signals to pass through the distal structure to and/or from the implantable device.
    Type: Application
    Filed: December 22, 2017
    Publication date: June 28, 2018
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: BRIAN SOLTIS, BRENDAN E. KOOP, BENJAMIN J. HAASL, KURT G. KOUBAL, JAMES P. GOODMAN, VINCENT P. HACKENMUELLER
  • Publication number: 20170368360
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Application
    Filed: June 26, 2017
    Publication date: December 28, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: STEPHEN J. HAHN, KRZYSZTOF Z. SIEJKO, WILLIAM J. LINDER, KEITH R. MAILE, AMY JEAN BRISBEN, KEITH L. HERRMANN, BRENDAN E. KOOP, BENJAMIN J. HAASL
  • Publication number: 20170319845
    Abstract: Tunneling tools and systems comprising electrodes and tunneling tool. In some examples the tunneling tools have a width that is greater than thickness, or may have enlarged portions to allow tunneling of a space. The tunneling tools may have expandable dissection portions including expandable balloons, linkages and/or springs in different examples. Systems may include tunneling tools with a lumen for receiving a lead having an electrode in a collapsed configuration, where the electrode is designed to expand once placed in a patient, with the tunneling tool designed to create a space in which the electrode can expand.
    Type: Application
    Filed: May 4, 2017
    Publication date: November 9, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: ANDREW L. DE KOCK, G. SHANTANU REDDY, ROBERT D. BROCK, II, STEPHEN J. HAHN, BRENDAN E. KOOP, MOIRA B. SWEENEY, WYATT K. STAHL